Oncology Nursing News®

Blood Cancers

There Are 'Tremendous Reasons to Be Hopeful' in Myeloma

There Are 'Tremendous Reasons to Be Hopeful' in Myeloma

BY SASCHA A. TUCHMAN, MD, MHS

Decrease Patient Stress: Keep MRD in the Academic Setting

Decrease Patient Stress: Keep MRD in the Academic Setting

BY BARRY PAUL, MD

Nurses Are Crucial in the Myeloma Treatment Team

Nurses Are Crucial in the Myeloma Treatment Team

BY JOSHUA RICHTER, MD

Reducing Transfusion Burden in Patients With Beta-Thalassemia

Reducing Transfusion Burden in Patients With Beta-Thalassemia

BY LYNNE LEDERMAN, PHD

CAR-T Therapy Is Promising for Older, Difficult-to-Treat Patients With NHL

CAR-T Therapy Is Promising for Older, Difficult-to-Treat Patients With NHL

BY HANNAH SLATER

Drug Combo Shows 100% ORR in Non-Hodgkin Lymphoma Subset

Drug Combo Shows 100% ORR in Non-Hodgkin Lymphoma Subset

BY GINA COLUMBUS

Early Steroid Use Reduces Cytokine Release Syndrome Risk With Axi-Cel Treatment

Early Steroid Use Reduces Cytokine Release Syndrome Risk With Axi-Cel Treatment

BY WAYNE KUZNAR

FDA Grants Breakthrough Therapy Designation for GVHD Prevention Drug

FDA Grants Breakthrough Therapy Designation for GVHD Prevention Drug

BY BRIELLE BENYON

More Than JAK Inhibitors Are Needed to Treat Patients with Myelofibrosis

More Than JAK Inhibitors Are Needed to Treat Patients with Myelofibrosis

BY ELLIE LEICK

Overcoming Sequencing Challenges in Myeloma

Overcoming Sequencing Challenges in Myeloma

BY ELLIE LEICK

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.